Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Forbion Capital Partners
1202
Forbion Capital Partners
Forbion Capital Partners invests in Life Sciences and Biomedical Technology companies developing worldclass drugs and technologies, with a clear focus on product development..
Suggest edits
Type
B2b
Founded
2007
Follow us
Companies in the same industry
Albion Capital
Charlesbank Capital Partners
Five Arrows Principal Investments
Beyond Ventures
Trive Capital
Kinara Capital
Generate Capital
Robo Global Robotics & Automation
Olympus Partners
Aeris Partners
Overview
News
Investments
24
Portfolio
Portfolio Tracker
Add info
Akarna Therapeutics
Biotechnology +1
Total funding
$15M in
1 rounds
from 3 investors
By Forbion Capital Partners
$15M Series B in Feb, 2016
Exit
Allergan plc
, Sep 20, 2016
Allecra Therapeutics
Biotechnology +1
Total funding
$44.6M in
1 rounds
from 5 investors
By Forbion Capital Partners
€22M Series B in Jun, 2016
Azafaros
Health Care +1
Total funding
$27.8M in
1 rounds
from 3 investors
By Forbion Capital Partners
€25M Series A in Feb, 2020
BioVex
Biotechnology
Total funding
$143.3M in
4 rounds
from 11 investors
By Forbion Capital Partners
$40M Series F in Mar, 2009
Exit
Amgen Inc.
, Jan 25, 2011
bluebird bio
Biotechnology
Total funding
$384.3M in
5 rounds
from 10 investors
By Forbion Capital Partners
$60M Series D in Jul, 2012
Cellnovo
Health Care +1
Total funding
$74.2M in
3 rounds
from 8 investors
By Forbion Capital Partners
$48.3M Series B in Feb, 2011
Dyne Therapeutics
Biotechnology +1
Total funding
$165M in
2 rounds
from 9 investors
By Forbion Capital Partners
$50M Series A in Apr, 2019
Exosome Diagnostics
Biotechnology +1
Total funding
$156.1M in
6 rounds
from 11 investors
By Forbion Capital Partners
$30M Series C in Jul, 2017
Hookipa Pharma
Health Care +2
Total funding
$101.7M in
3 rounds
from 9 investors
By Forbion Capital Partners
$59.6M Series C in Dec, 2017
KaNDy Therapeutics
Health Care +1
Total funding
$32.9M in
1 rounds
from 5 investors
By Forbion Capital Partners
£25M Series C in Aug, 2018
Exit
Bayer
, Aug 11, 2020
Milestone Pharmaceuticals, Inc.
Biotechnology
Total funding
$165M in
4 rounds
from 13 investors
By Forbion Capital Partners
$55M Series C in Aug, 2017
NeRRe Therapeutics
Fitness +2
Total funding
$47M in
2 rounds
from 7 investors
By Forbion Capital Partners
£23M Series B in Jan, 2017
NorthSea Therapeutics
Health Care +2
Total funding
$69.8M in
2 rounds
from 9 investors
By Forbion Capital Partners
€25M Series A in Dec, 2017
PneumRx, Inc., a BTG International group company
Health Care
Total funding
$33M in
1 rounds
from 8 investors
By Forbion Capital Partners
$33M Venture capital in Jan, 2011
Exit
BTG
, Dec 4, 2014
Prexton Therapeutics SA
Health and Wellness +3
Total funding
$41.2M in
2 rounds
from 5 investors
By Forbion Capital Partners
€29M Series B in Feb, 2017
Prilenia
Biotechnology +1
Total funding
$62.5M in
1 rounds
from 4 investors
By Forbion Capital Partners
$62.5M Series A in Jun, 2020
Rigontec GmbH
Medical +2
Total funding
$35.2M in
1 rounds
from 6 investors
By Forbion Capital Partners
€15M Series A in Sep, 2016
Want to see the complete list?
Go Pro!
